Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science

Published:2016-02-02 Issue:2 Volume:19 Page:111-121
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Nussbaum N,George D J,Abernethy A P,Dolan C M,Oestreicher N,Flanders S,Dorff T B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan201542.pdf

Reference83 articles.

1. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29.

2. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H . Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 2001; 165: 1146–1151.

3. Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA . Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer 2004; 100: 1283–1292.

4. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 2003; 57: 915–928.

5. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A . Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005; 63: 1463–1468.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management;Current Treatment Options in Oncology;2024-06-24

3. Metastatic castration resistant prostate cancer patients’ experience with Radium-223 treatment in Japan;Future Oncology;2024-01-26

4. PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence;Clinical Genitourinary Cancer;2023-12

5. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway;Biochemical Pharmacology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3